Triethylamine → 5-(6-(4-(ethylsulfonyl)piperazin-1-yl)pyridin-3-yl)-3-(1-(3-fluorobenzyl)-1H-pyrazol-4-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine
Reaction equation
COC1C=CC(B2OC(C)(C)C(C)(C)O2)=C[C:4]=1[CH2:18][S:19](N)(=[O:21])=[O:20].[F:23][C:24]1[CH:25]=[C:26]([CH:64]=[CH:65][CH:66]=1)[CH2:27][N:28]1[CH:32]=[C:31]([C:33]2[C:41]3[C:36](=[N:37][CH:38]=[C:39]([C:42]4[CH:43]=[N:44][C:45]([N:48]5[CH2:53][CH2:52][NH:51][CH2:50][CH2:49]5)=[CH:46][CH:47]=4)[CH:40]=3)[N:35]([S:54]([C:57]3[CH:63]=[CH:62][C:60]([CH3:61])=[CH:59][CH:58]=3)(=[O:56])=[O:55])[CH:34]=2)[CH:30]=[N:29]1.FC1C=C(C=CC=1)CN1C=C(C2C3C(=NC=C(C4C=NC(N5CCN(C)CC5)=CC=4)C=3)NC=2)C=N1.C(S(Cl)(=O)=O)C.C(N(CC)CC)C>C(Cl)Cl>[CH2:18]([S:19]([N:51]1[CH2:52][CH2:53][N:48]([C:45]2[N:44]=[CH:43][C:42]([C:39]3[CH:40]=[C:41]4[C:33]([C:31]5[CH:30]=[N:29][N:28]([CH2:27][C:26]6[CH:64]=[CH:65][CH:66]=[C:24]([F:23])[CH:25]=6)[CH:32]=5)=[CH:34][N:35]([S:54]([C:57]5[CH:63]=[CH:62][C:60]([CH3:61])=[CH:59][CH:58]=5)(=[O:56])=[O:55])[C:36]4=[N:37][CH:38]=3)=[CH:47][CH:46]=2)[CH2:49][CH2:50]1)(=[O:21])=[O:20])[CH3:4]Participants
7
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
Using similar reaction conditions as described in step i of intermediate 17, 3-(1-(3-fluorobenzyl)-1H-pyrazol-4-yl)-5-(6-(piperazin-1-yl)pyridin-3-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine (step 1 compound of example 137) (80 mg, 0.13 mmol) was alkylated with ethanesulfonyl chloride (25 mg, 0.196 mmol) using triethylamine (40 mg, 0.39 mmol) in DCM (3 mL) to afford 100 mg (100% yield) of the titled compound. MS: m/z=700.2 (M+1).
Workup
- customreaction conditions
Sources & evidence
- ORD record
- ord-70f5fee1d6cc4fef8fd78804f6de5a9e
- Source dataset
- uspto-grants-2016_05
- Patent number
- US09353107B2
Reaction notes
Loading…